| Document And Entity Information | Aug. 08, 2022 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Aug. 08, 2022 |
| Entity Registrant Name | Turning Point Therapeutics, Inc. |
| Entity Central Index Key | 0001595893 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-38871 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 46-3826166 |
| Entity Address, Address Line One | 10628 Science Center Drive, Ste. 200 |
| Entity Address, City or Town | San Diego |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 92121 |
| City Area Code | 858 |
| Local Phone Number | 926-5251 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.0001 par value per share |
| Trading Symbol | TPTX |
| Security Exchange Name | NASDAQ |
